BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 6, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Jan. 29, 2020

Jan. 29, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including Akcea, Delmar, Emmaus, Exopharm, Geneos, Intercept, Orexo, Satsuma, Unum, Vasopharm, Verastem
Read More

In the clinic for Jan. 28, 2020

Jan. 28, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: On Target Laboratories
Read More

In the clinic for Jan. 28, 2020

Jan. 28, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Acceleron, Aeterna Zentaris, Bausch Health, Cassava, Clearside, Ikena, Incyte, Syros
Read More

Clinical data for Jan. 21-27, 2020

Jan. 28, 2020
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Beigene, Cstone, Daiichi Sankyo, Epygenix, Hutchison China Meditech, Isofol Medical, Oric
Read More

In the clinic for Jan. 27, 2020

Jan. 27, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Saluda Medical, Soliton
Read More

In the clinic for Jan. 27, 2020

Jan. 27, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Anavex, Astellas, Astrazeneca, Aveo, Daiichi, Deinove, Epygenix, Evolus, Faron, Hansa, Innovation, Khondrian, Lilly, Nucana, Oncimmune, Oric, Sun Biopharma, Trovagene
Read More

In the clinic for Jan. 24, 2020

Jan. 24, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Bellicum, Cstone, Erytech, Exelixis, Ipsen, Isofol, Lipidor, Roche, Tonix
Read More

In the clinic for Jan. 23, 2020

Jan. 23, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Abbott Laboratories
Read More

In the clinic for Jan. 23, 2020

Jan. 23, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Applied Genetic Technologies, Blackthorn, Genentech, Horizon, Leap, Lipomedix
Read More

In the clinic for Jan. 22, 2020

Jan. 22, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Medtronic
Read More
Previous 1 2 … 291 292 293 294 295 296 297 298 299 … 311 312 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 5, 2026.
  • Sickle cell illustration

    AND-017 increases RBC and hemoglobin in sickle cell disease

    BioWorld Science
    Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing